We began developing the idea for our first non-invasive cancer biomarker test, Melaseq™, in 2016.
Below is a timeline of our progress and milestones.
Melanoma Genomic database created
Accepted to Melbourne Health Accelerator Spring 2017 Cohort
Geneseq Biosciences invited to participate in Australia’s first hospital ‘in-situ’ accelerator program, in association with Health Round Table. The MHx program provides innovative start-up companies with the opportunity to access the world-class Royal Melbourne Hospital health system and empowers clinicians and researchers to pursue an entrepreneurial mindset within a structured collaborative framework.